Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
NCT07497087 Nerandomilast CREST Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07497087 Nerandomilast CREST Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07497087 clinical trial report covering Nerandomilast, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07499817 Pentoxifylline Infertility Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07499817 Pentoxifylline Infertility Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07499817 clinical trial report covering Pentoxifylline, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07500207 Rabies vaccine (Changchun BCHT ) Rabies Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07500207 Rabies vaccine (Changchun BCHT ) Rabies Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07500207 clinical trial report covering Rabies vaccine (Changchun BCHT ), Phase 3, endpoints, sponsor, geography, readout timing and development white s
Read →
NCT07500090 Pitolisant Hydrochloride Idiopathic Hypersomnia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07500090 Pitolisant Hydrochloride Idiopathic Hypersomnia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07500090 clinical trial report covering Pitolisant Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07501832 Bofanglutide Sleep Apnea, Obstructive Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07501832 Bofanglutide Sleep Apnea, Obstructive Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07501832 clinical trial report covering Bofanglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07499115 Chitosan Dental Plaque Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07499115 Chitosan Dental Plaque Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07499115 clinical trial report covering Chitosan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07499674 VGT-309 Secondary malignant neoplasm of lung Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07499674 VGT-309 Secondary malignant neoplasm of lung Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07499674 clinical trial report covering VGT-309, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20254614 HR1405-01 Pain, Postoperative Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20254614 HR1405-01 Pain, Postoperative Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20254614 clinical trial report covering HR1405-01, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07500506 VLA15 Lyme Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07500506 VLA15 Lyme Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07500506 clinical trial report covering VLA15, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07499232 Risankizumab-RZAA Crohn Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07499232 Risankizumab-RZAA Crohn Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07499232 clinical trial report covering Risankizumab-RZAA, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07499544 Libevitug Hepatitis D, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07499544 Libevitug Hepatitis D, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07499544 clinical trial report covering Libevitug, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07502300 Tislelizumab Extensive stage Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07502300 Tislelizumab Extensive stage Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07502300 clinical trial report covering Tislelizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →